miR-532-3p Inhibits Proliferation and Promotes Apoptosis of Lymphoma Cells by Targeting β -Catenin

Conclusion: This study demonstrates that miR-532-3p functions as a tumor inhibitor in lymphoma progression by targeting β-catenin, suggesting miR-532-3p/β-catenin as a new diagnosis marker or potential therapeutic target in lymphoma.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Yan Liu, Qiuying Li, Yongzhou Dai, Tinghui Jiang, Yongming Zhou Tags: Research Paper Source Type: research